Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2014, Article ID 596245, 5 pages
http://dx.doi.org/10.1155/2014/596245
Research Article

Identification and In Vitro Antimicrobial Susceptibility of Brucella Species Isolated from Human Brucellosis

1Bacteriology Unit, Infectious Disease Research Centre, Institute for Medical Research, Jalan Pahang, 50588 Kuala Lumpur, Malaysia
2Microbiology Unit, Department of Pathology, Hospital Pulau Pinang, Jalan Residensi, 10990 Georgetown, Pulau Pinang, Malaysia
3Infectious Disease Unit, Medical Department, Jalan Residensi, 10990 Georgetown, Pulau Pinang, Malaysia

Received 25 April 2014; Accepted 15 June 2014; Published 10 July 2014

Academic Editor: Joseph Falkinham

Copyright © 2014 Rohaidah Hashim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Pappas, P. Papadimitriou, N. Akritidis, L. Christou, and E. V. Tsianos, “The new global map of human brucellosis,” The Lancet Infectious Diseases, vol. 6, no. 2, pp. 91–99, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. E. J. Young, Principles and Practice of Infectious Diseases, edited by G. L. Mandell, J. E. Bennet, R. Dolin, Churchill Livingstone, Philadelphia , Pa, USA, 6th edition, 2005.
  3. T. F. Black, “Brucellosis,” in Infectious Diseases, J. Cohen and W. G. Powderly, Eds., pp. 1665–1667, Mosby, St. Louis, Mo, USA, 2nd edition, 2004. View at Google Scholar
  4. P. G. Joseph, “Major Bacterial diseases in Malaysia, their prevalence, detection and control,” in Proceedings of the 5th FAO Regional Conference on Animal Production and Health in the Far East, Kuala Lumpur, 1971.
  5. A. R. Bahaman, P. G. Joseph, and S. K. Bejo, “A review of the epidemiology and control of Brucellosis in Malaysia,” Jurnal Veterinar Malaysia, vol. 19, no. 1, pp. 1–6, 2007. View at Google Scholar
  6. Joint Food and Agriculture Organization/World Health Organization, “FAO-WHO expert committee on Brucellosis (seventh report),” WHO Technical Report 740, World Health Organisation, Geneva, Switzerland, 2006. View at Google Scholar
  7. E. Tanyel, A. Y. Coban, S. T. Koruk et al., “Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region,” Saudi Medical Journal, vol. 28, no. 8, pp. 1239–1242, 2007. View at Google Scholar · View at Scopus
  8. E. Ayaslioglu, S. Kiliç, K. Aydin, D. Kiliç, S. Kaygusuz, and C. Agalar, “Antimicrobial susceptibility of Brucella melitensis isolates from blood samples,” Turkish Journal of Medical Sciences, vol. 38, no. 3, pp. 257–262, 2008. View at Google Scholar
  9. H. Aliskan, T. Turunc, Y. Z. Demiroglu, S. Colakoglu, and H. Arslan, “Investigation of in vitro antibiotic susceptibility of Brucella melitensis,” Mikrobiyoloji Bülteni, vol. 42, no. 1, pp. 125–129, 2008. View at Google Scholar
  10. T. Dimitrov, D. Panigrahi, M. Emara, F. Awni, and R. Passadilla, “Seroepidemiological and microbiological study of brucellosis in Kuwait,” Medical Principles and Practice, vol. 13, no. 4, pp. 215–219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Lopez-Merino, A. Contreras-Rodriguez, R. Migranas-Ortiz et al., “Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis,” Scandinavian Journal of Infectious Diseases, vol. 36, no. 9, pp. 636–638, 2004. View at Google Scholar
  12. Clinical and Laboratory Standards Institute (CLSI), Method for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria, M45-A2, 2nd edition, 2013.
  13. Clinical and Laboratory Standards Institute (CLSI), M100-S24: Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement, Clinical and Laboratory Standards Institute (CLSI), 2014.
  14. R. S. Weyant, Identification of Unusual Pathogenic Gram-Negative Aerobic and Facultatively Anaerobic Bacteria, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 1996.
  15. P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken, Manual of Clinical Microbiology, American Society for Microbiology, 7th edition, 1999.
  16. M. G. Mense, R. H. Borschel, C. L. Wilhelmsen, M. L. Pitt, and D. L. Hoover, “Pathologic changes associated with brucellosis experimentally induced by aerosol exposure in rhesus macaques (Macaca mulatta),” American Journal of Veterinary Research, vol. 65, no. 5, pp. 644–652, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Marianelli, C. Graziani, C. Santangelo et al., “Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy,” Journal of Clinical Microbiology, vol. 45, no. 9, pp. 2923–2928, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Abdel-Maksoud, B. House, M. Wasfy et al., “In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance,” Annals of Clinical Microbiology and Antimicrobials, vol. 11, article 24, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. I. Morales-Estrada, J. Castillo-Salto, A. López-Merino, M. R. Morales-García, J. G. Valle-Valdez, and A. Contreras-Rodríguez, “Characterization of Brucella species in Mexico by Bruce-Ladder polymerase chain reaction (PCR),” African Journal of Microbiology Research, vol. 6, no. 11, pp. 2793–2796, 2012. View at Publisher · View at Google Scholar
  20. E. Rubinstein, R. Lang, B. Shasha et al., “In vitro susceptibility of Brucella melitensis to antibiotics,” Antimicrobial Agents and Chemotherapy, vol. 35, no. 9, pp. 1925–1927, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Yamazhan, Ş. Aydemir, A. Tünger, D. Serter, and D. Gökengin, “In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean Region in Turkey,” Medical Principles and Practice, vol. 14, no. 6, pp. 413–416, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Bodur, N. Balaban, S. Aksaray et al., “Biotypes and antimicrobial susceptibilities of Brucella isolates,” Scandinavian Journal of Infectious Diseases, vol. 35, no. 5, pp. 337–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Gur, S. Kocagoz, M. Akova, and S. Unal, “Comparison of E test to microdilution for determining of in vitro activities of antibioticsagainst Brucella melitensis,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 9, p. 2337, 1999. View at Google Scholar · View at Scopus
  24. Y. M. El Miedany, M. El Gaafary, M. Maddour, and I. Ahmed, “Human brucellosis: do we need to revise our therapeutic policy?” Journal of Rheumatology, vol. 30, no. 12, pp. 2666–2672, 2003. View at Google Scholar · View at Scopus
  25. K. Skalsky, D. Yahav, J. Bishara, S. Pitlik, L. Leibovici, and M. Paul, “Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials,” British Medical Journal, vol. 336, no. 7646, pp. 701–704, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. M. P. Franco, M. Mulder, and H. L. Smits, “Persistence and relapse in brucellosis and need for improved treatment,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 101, no. 9, pp. 854–855, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Pappas, N. Akritidis, M. Bosilkovski, and E. Tsianos, “Brucellosis,” The New England Journal of Medicine, vol. 352, no. 22, pp. 2325–2367, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Turkmani, A. Ioannidis, A. Christidou, A. Psaroulaki, F. Loukaides, and Y. Tselentis, “In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics,” Annals of Clinical Microbiology and Antimicrobials, vol. 5, article 24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Akova, D. Gür, D. M. Livermore, T. Kocagöz, and H. E. Akalin, “In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 5, pp. 1298–1300, 1999. View at Google Scholar · View at Scopus
  30. R. C. Maves, R. Castillo, A. Guillen et al., “Antimicrobial susceptibility of Brucella melitensis isolates in Peru,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 3, pp. 1279–1281, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Bosch, J. Linares, M. J. Lopez de Goicoechea, J. Ariza, M. C. Cisnal, and R. Martin, “In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis,” Journal of Antimicrobial Chemotherapy, vol. 17, no. 4, pp. 459–461, 1986. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Solera, A. Espinosa, E. Martínez-Alfaro et al., “Treatment of human brucellosis with doxycycline and gentamicin,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 1, pp. 80–84, 1997. View at Google Scholar · View at Scopus
  33. Y. Bayram, H. Korkoca, C. Aypak et al., “Antimicrobial susceptibilities of Brucella isolates from various clinical speciemens,” International Journal of Medical Sciences, vol. 8, no. 3, pp. 198–202, 2011. View at Google Scholar · View at Scopus
  34. G. Şengöz, K. K. Yaşar, S. B. Kutlu, Y. B. Durdu, R. Özdemir, and Ö. Nazlican, “E-test susceptibility results of Brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline,” Mikrobiyoloji Bulteni, vol. 40, no. 3, pp. 265–268, 2006. View at Google Scholar · View at Scopus
  35. N. Baykam, H. Esener, Ö. Ergönül, Ş. Eren, A. K. Çelikbas, and B. Dokuzoǧuz, “In vitro antimicrobial susceptibility of Brucella species,” International Journal of Antimicrobial Agents, vol. 23, no. 4, pp. 405–407, 2004. View at Publisher · View at Google Scholar · View at Scopus